Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Melinta Therapeutics
Melinta Therapeutics
Venatorx, Melinta's BARDA-funded antibiotic combo falls short with manufacturing-related rejection
Fierce Pharma
Sun, 02/25/24 - 08:59 pm
antibiotics
VenatoRx
Melinta Therapeutics
drug manufacturing
BARDA
FDA approves new antifungal as concerns grow over drug-resistant fungus
BioPharma Dive
Thu, 03/23/23 - 08:53 pm
FDA
Cidara Therapeutics
Melinta Therapeutics
antifungals
candidemia
candidiasis
Rezzayo
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
FDA
Acadia Pharmaceuticals
Apellis Pharmaceuticals
AstraZeneca
Biogen
Biomarin
Cidara Therapeutics
Emergent BioSolutions
GSK
Incyte
Ionis Pharmaceuticals
Melinta Therapeutics
Mundipharma
Novartis
Pfizer
Pharming
Regeneron
Roche
vaccines
RSV
ALS
COVID-19
FDA advisers back Cidara and Melinta’s antifungal treatment
BioPharma Dive
Thu, 01/26/23 - 10:42 am
FDA
Cidara Therapeutics
Melinta Therapeutics
antifungals
candidemia
candidiasis
rezafungin
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition
Xconomy
Tue, 06/9/20 - 11:24 pm
Melinta Therapeutics
Tetraphase
M&A
antibiotics
As it happened: A bidding war for an antibiotic maker in a market that has ravaged its peers
Endpoints
Fri, 06/5/20 - 11:01 am
antibiotics
M&A
Tetraphase
AcelRx
Melinta Therapeutics
La Jolla Pharmaceutical
Melinta's Bankruptcy Underlines Problems with the Antibiotics Market
BioSpace
Fri, 03/6/20 - 11:28 pm
Melinta Therapeutics
bankruptcy
antibiotics
Melinta’s Chapter 11 Auction Draws No Bids, Deerfield to Get Asset
Xconomy
Wed, 03/4/20 - 07:56 pm
Melinta Therapeutics
Chapter 11
bankruptcy
Melinta seeks buyout bids to secure escape from bankruptcy
Fierce Biotech
Fri, 02/14/20 - 10:43 am
Melinta Therapeutics
M&A
bankruptcy
Antibiotics maker Melinta files for Chapter 11 bankruptcy
Reuters
Wed, 01/1/20 - 07:08 pm
Melinta Therapeutics
Chapter 11
bankruptcy
antibiotics
FDA OKs new use for Melinta's Baxdela; shares down 26% premarket on potential capital raise
Seeking Alpha
Fri, 10/25/19 - 10:37 am
Melinta Therapeutics
FDA
Baxdela
community-acquired bacterial pneumonia
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
Yahoo/Benzinga
Sun, 10/20/19 - 05:18 pm
earnings
Eli Lilly
Alexion
Gilead Sciences
Biomarin
Edwards Lifesciences
Baxter International
Integra LifeSciences
Phathom Pharmaceuticals
IPOs
Foamix
Eton Pharmaceuticals
Melinta Therapeutics
Ligand Pharmaceuticals
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/23/19 - 02:04 pm
Merck
Keytruda
Melinta Therapeutics
Amag Pharmaceuticals
Palatin
Acer Therapeutics
Sanofi
Regeneron
Alexion
Pfizer
Roche
Navidea Biopharmaceuticals
Ascendis Pharma
Scholar Rock
Adaptive Biotechnologies
BridgeBio
IPOs
G Medical Innovations
Karuna
Morphic Therapeutics
In starved antibiotic field, Melinta soars as FDA grants speedy drug review
Endpoints
Thu, 06/20/19 - 09:53 am
Melinta Therapeutics
antibiotics
Baxdela
community-acquired bacterial pneumonia
FDA
priority review
John Johnson is back trying his hand as a turnaround artist for a troubled biotech. Can he win this time?
Endpoints
Thu, 12/20/18 - 12:20 am
Melinta Therapeutics
John Johnson
Pharma CEOs
Several CEOs and 17 years later, Melinta scores an FDA OK for its antibiotic
Endpoints
Mon, 06/19/17 - 11:35 pm
Melinta Therapeutics
FDA
antibiotics
delafloxacin
Baxdela
Antibiotics developer Melinta lands a $70M round for PhIII development
Fierce Biotech
Mon, 02/10/14 - 05:48 pm
Melinta Therapeutics
antibiotics
delafloxacin
How the Game Changed Against Big Pharma - Creating New Opportunities
Forbes
Wed, 10/9/13 - 03:58 pm
Merck
Pfizer
Eli Lilly
Big Pharma
Sanofi
Roche
GSK
Abbott Laboratories
Melinta Therapeutics
antibiotics
delafloxacin